These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19387113)

  • 1. Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes.
    Jones A; Kulozik P; Ostertag A; Herzig S
    J Alzheimers Dis; 2009; 16(4):787-808. PubMed ID: 19387113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
    Granic I; Dolga AM; Nijholt IM; van Dijk G; Eisel UL
    J Alzheimers Dis; 2009; 16(4):809-21. PubMed ID: 19387114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease.
    Moreira PI; Duarte AI; Santos MS; Rego AC; Oliveira CR
    J Alzheimers Dis; 2009; 16(4):741-61. PubMed ID: 19387110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
    Rao AA; Sridhar GR; Das UN
    Med Hypotheses; 2007; 69(6):1272-6. PubMed ID: 17553629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust signaling networks of the adipose secretome.
    Breitling R
    Trends Endocrinol Metab; 2009 Jan; 20(1):1-7. PubMed ID: 18930409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
    Caraci F; Copani A; Nicoletti F; Drago F
    Eur J Pharmacol; 2010 Jan; 626(1):64-71. PubMed ID: 19837057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.
    Rosales-Corral S; Tan DX; Manchester L; Reiter RJ
    Oxid Med Cell Longev; 2015; 2015():985845. PubMed ID: 25815110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transition from physiological to pathophysiological indices as exemplified by amyloidosis in periodic disease, non-insulin-dependent diabetes mellitus, and Alzheimer's disease].
    Piruzian LA; Leksina LA
    Fiziol Cheloveka; 2009; 35(1):107-20. PubMed ID: 19323434
    [No Abstract]   [Full Text] [Related]  

  • 12. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
    de Jong D; Jansen RW; Verbeek MM; Kremer HP
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc modification in diabetes and Alzheimer's disease.
    Dias WB; Hart GW
    Mol Biosyst; 2007 Nov; 3(11):766-72. PubMed ID: 17940659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes.
    Beeler N; Riederer BM; Waeber G; Abderrahmani A
    Brain Res Bull; 2009 Oct; 80(4-5):274-81. PubMed ID: 19616077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common pathological processes in Alzheimer disease and type 2 diabetes: a review.
    Li L; Hölscher C
    Brain Res Rev; 2007 Dec; 56(2):384-402. PubMed ID: 17920690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
    Collister KA; Albensi BC
    Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
    Kroner Z
    Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Links between Alzheimer's disease and diabetes.
    Sun MK; Alkon DL
    Timely Top Med Cardiovasc Dis; 2006 Oct; 10():E24. PubMed ID: 17066144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological interaction between diabetes mellitus and Alzheimer's disease].
    Takeda S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Nov; 32(5-6):239-44. PubMed ID: 23373309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.